Study Purpose: This study looks into how well women with breast cancer do after receiving a type of treatment called neoadjuvant chemotherapy (NAC). We're using smart computer programs, like artificial intelligence (AI), to predict how patients might respond to this treatment.
Who Can Join: We're looking for women who had invasive breast cancer and got NAC between 2008 and 2019. You need to have had certain scans and tests done before and after treatment. We're not looking for those who had other treatments before NAC, had the cancer spread during NAC, or have other cancers.
- Study Length: Data will be collected until December 31, 2024.
- Visits: No extra visits are needed as we use existing data.
- Eligibility: Must have breast cancer, received NAC, and have specific medical records.
This study helps us understand breast cancer better, but it doesn't offer treatment or changes to your care plan.
How understandable was the trial content above?
Hard to understand
Easy to understand